Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (38)
COVID-19 (12)
Type
Type
Guidance (1907)
NICE advice (319)
Quality standard (199)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (226)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (19)
Highly specialised technologies guidance (28)
Interventional procedures guidance (604)
Medical technologies guidance (66)
Medicines practice guidelines (5)
NICE guidelines (342)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (798)
Advice programme
Advice programme
Evidence summaries (67)
Medtech innovation briefings (252)
Apply filters
Showing 601 to 650 of 2425
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Brain tumours (primary) and brain metastases in over 16s
QS203
7 December 2021
7 December 2021
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders
TA748
1 December 2021
1 December 2021
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)
TA749
1 December 2021
1 December 2021
Synergo for non-muscle-invasive bladder cancer
MTG61
30 November 2021
30 November 2021
CerebAir for continuous EEG monitoring in intensive care
MIB279
30 November 2021
30 November 2021
Paige Prostate for prostate cancer
MIB280
30 November 2021
30 November 2021
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemia
MIB278
30 November 2021
30 November 2021
Fever in under 5s: assessment and initial management
NG143
7 November 2019
26 November 2021
Givosiran for treating acute hepatic porphyria
HST16
24 November 2021
24 November 2021
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure
IPG711
24 November 2021
24 November 2021
Coronary sinus narrowing device implantation for refractory angina
IPG712
24 November 2021
24 November 2021
Chronic kidney disease: assessment and management
NG203
25 August 2021
24 November 2021
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer
TA746
17 November 2021
17 November 2021
Nintedanib for treating progressive fibrosing interstitial lung diseases
TA747
17 November 2021
17 November 2021
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea
DG44
17 November 2021
17 November 2021
Acute heart failure: diagnosis and management
CG187
8 October 2014
17 November 2021
Heart valve disease presenting in adults: investigation and management
NG208
17 November 2021
17 November 2021
Upadacitinib for treating moderate rheumatoid arthritis
TA744
10 November 2021
10 November 2021
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)
TA745
10 November 2021
10 November 2021
Inducing labour
NG207
4 November 2021
4 November 2021
Inducing labour
QS60
17 April 2014
4 November 2021
Selpercatinib for treating advanced thyroid cancer with RET alterations
TA742
3 November 2021
3 November 2021
24/7 EEG SubQ for epilepsy
MIB277
2 November 2021
2 November 2021
Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management
NG206
29 October 2021
29 October 2021
Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancer
TA740
28 October 2021
28 October 2021
Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer
TA741
28 October 2021
28 October 2021
Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitable
TA739
27 October 2021
27 October 2021
Genicular artery embolisation for pain from knee osteoarthritis
IPG708
27 October 2021
27 October 2021
Laparoscopic renal denervation for loin pain haematuria syndrome
IPG709
27 October 2021
27 October 2021
Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access
IPG710
27 October 2021
27 October 2021
Tofacitinib for treating juvenile idiopathic arthritis
TA735
20 October 2021
20 October 2021
Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy
TA736
20 October 2021
20 October 2021
Berotralstat for preventing recurrent attacks of hereditary angioedema
TA738
20 October 2021
20 October 2021
Looked-after children and young people
NG205
20 October 2021
20 October 2021
Secukinumab for treating moderate to severe plaque psoriasis in children and young people
TA734
7 October 2021
7 October 2021
Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal)
TA732
6 October 2021
6 October 2021
Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia
TA733
6 October 2021
6 October 2021
DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography
MTG60
4 October 2021
4 October 2021
Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)
TA730
29 September 2021
29 September 2021
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)
TA731
29 September 2021
29 September 2021
Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)
TA726
22 September 2021
22 September 2021
Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)
TA727
22 September 2021
22 September 2021
Midostaurin for treating advanced systemic mastocytosis
TA728
22 September 2021
22 September 2021
Sapropterin for treating hyperphenylalaninaemia in phenylketonuria
TA729
22 September 2021
22 September 2021
Lateral elbow resurfacing for arthritis
IPG705
22 September 2021
22 September 2021
Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis
IPG706
22 September 2021
22 September 2021
Transapical transcatheter mitral valve-in-ring implantation after failed annuloplasty for mitral valve repair
IPG707
22 September 2021
22 September 2021
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
TA725
15 September 2021
15 September 2021
OrganOx metra for liver transplant
MIB275
14 September 2021
14 September 2021
Carnation Ambulatory Monitor for ambulatory detection of cardiac arrythmias
MIB276
14 September 2021
14 September 2021
Previous page
1
…
11
12
Current page
13
14
15
…
49
Page
13
of
49
Next page
Results per page
10
25
50
All
Back to top